Elias‐Sonnenschein et al. (2013) tested if different MAPT rs1467967 and rs7521 genotypes affected the levels of Aβ1–42, t‐tau and p‐tau181 in AD patients. The gene discussed is MAPT; the disease is Alzheimer disease.